Trondheim, Norway

Endre Bakken Stovner

This inventor holds 1 USPTO granted patent and 5 published patent applications, plus 1 CIPO patent. Top assignee: Mina Therapeutics Limited. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Endre Bakken Stovner. Retrieved from https://idiyas.com/inventor/endre-bakken-stovner

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0


Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Endre Bakken Stovner: Innovator in saRNA Therapeutics

Introduction

Endre Bakken Stovner is a notable inventor based in Trondheim, Norway. He has made significant contributions to the field of therapeutic compositions, particularly through his innovative work on saRNA targeting.

Latest Patents

Stovner holds a patent for "C/EBP alpha saRNA compositions and methods of use." This invention relates to saRNA that targets a C/EBPα transcript, along with therapeutic compositions that comprise this saRNA. The methods of using these therapeutic compositions are also outlined in his patent.

Career Highlights

Stovner is associated with Mina Therapeutics Limited, where he applies his expertise in the development of novel therapeutic solutions. His work focuses on advancing the understanding and application of saRNA technologies.

Collaborations

Stovner collaborates with notable colleagues, including Andreas Wagner and Robert Habib, who contribute to the innovative environment at Mina Therapeutics Limited.

Conclusion

Endre Bakken Stovner is a pioneering inventor whose work in saRNA therapeutics is paving the way for new treatment methodologies. His contributions are significant in the realm of medical innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…